CIK 0001819790
- Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 814717861
- Phone
- +1 949-409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,995,859
- in 7 filings, $6.0M under 10b5-1 plans
Net −$5,995,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-20 | Greenstein Leonard M. Chief Financial Officer | Sale 10b5-1 | −5,000 | $14.02 | $70K | 26,785 |
| 2023-03-23 | Greenstein Leonard M. Chief Financial Officer | Sale | −346 | $12.15 | $4K | 31,785 |
| 2023-03-22 | Greenstein Leonard M. Chief Financial Officer | Sale | −332 | $12.64 | $4K | 32,131 |
| 2023-03-21 | Greenstein Leonard M. Chief Financial Officer | Sale | −326 | $12.89 | $4K | 32,463 |
| 2023-03-20 | Greenstein Leonard M. Chief Financial Officer | Sale | −333 | $12.61 | $4K | 32,789 |
| 2023-03-17 | Greenstein Leonard M. Chief Financial Officer | Sale | −316 | $13.28 | $4K | 33,122 |
| 2023-03-16 | Greenstein Leonard M. Chief Financial Officer | Sale | −313 | $13.43 | $4K | 38,438 |
| 2023-03-16 | Greenstein Leonard M. Chief Financial Officer | Sale | −5,000 | $13.44 | $67K | 33,438 |
| 2023-03-15 | Greenstein Leonard M. Chief Financial Officer | Exercise or conversion | +4,462 | 38,751 | ||
| 2023-03-15 | Greenstein Leonard M. Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −4,462 | 13,388 |
Page 1 of 1 · 10 trades